However, it must be considered that these data are preliminary and that the anti-androgenic effect of FICZ, which also reverberates on DHT and Prostate-Specific Antigen (PSA) levels, could be a serious side-effect of a hypothetical FICZ-based anti-COVID-19 therapy. Here, KLK3 is linked to COVID-19.